Global
Nanobiotechnology Market is Expected to Reach USD 46,870.5 Mn by 2023
The latest market
report published by Credence Research, Inc. “Global Nanobiotechnology Market -
Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2023,”
the nanobiotechnology market was valued at USD 31,450.8 Mn in 2015, and is expected
to reach USD 46,870.5 Mn by 2023, expanding at a CAGR of 8.7% from 2016 to
2023.
Browse the
full report Nanobiotechnology Market - Growth, Share, Opportunities,
Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/nanobiotechnology-market
Market
Insights:
Nanobiotechnology
market comprises of technologies such as bionanomaterials, nanoparticles,
nanocrystals, quantum dots, liposomes, polymer structures dendrimers,
nanopores, and intergrated nanostructures. The rising prevalence of cancer,
increasing public awareness related to novel treatments for cancer, and
constant technological upgradation in the field of nanotechnology research and
development.
The major restrains of
this market especially in emerging and underdeveloped economies are scarcity of
resources and mounting technological cost. However, rising demand from
pharmaceutical domain is expected to open up novel growth opportunities within
the forecast period. On the basis of application nanobiotechnology market is
segmented into drug delivery, sequencing, biologic imaging, research tools and
microbicide. Biotechnology and pharmaceutical industries are expected to remain
the largest end-users of nanobiotechnology. Market experts suggested that drug
delivery is the most crucial pharmaceutical application and now is the most
focused area in nanobiotechnology.
In drug delivery
application apart from solving solubility issues of drug it also assists to
enhance intracellular delivery possibilities and the level of skin permeability
in transdermal drug delivery. Nanobiotechnology has multitude of potentials for
advancing medical science, thus, developing health care practices around the
world. Nanobiotechnology is currently in initial stage and a few clinical
applications of nanotechnology are still practically inexistent. However, a
significant number of promising medical projects are ongoing at advanced
experimental stage.
Market
Competition Assessment:
The nanobiotechnology
market is observed as the most diversified and competitive market comprising
large number of players. The market is
dominated by several players, depending on their major competencies. The key
players in this market are Aduro BioTech, Calando Pharmaceuticals Inc., Baxter
International, Inc., Fresinuns Kabi AG, Smith & Nephew plc, Biosante
Phosphate Pharmaceuticals Inc., Celgene Corporation, Elan Pharmaceuticals Inc.,
Flamel Technologies Inc., Nanophase Technologies Corporation, Sigma Aldrich
Company, Dendritic Nanotechnologies Inc. and SkyePharma Pharmaceuticals.
Key Market
Movements:
Asia-Pacific was observed
as the fastest growing region throughout the forecast period 2016 – 2023 due to
rising public awareness related to cancer diagnosis and treatment, developing
healthcare services and research and development infrastructure, and high
market penetration and acceptance of novel treatment technologies
Drug delivery is the
most crucial pharmaceutical application and now is the most focused area in
nanobiotechnology
Nanobiotechnology
possess the capability to develop breakthrough interface systems between
physical objects and living cells to allow interaction of modern electronic
devices with biological systems
About Us:
Credence
Research is a worldwide market research and counseling firm that serves driving
organizations, governments, non legislative associations, and not-for-benefits.
We offer our customers some assistance with making enduring enhancements to
their execution and understand their most imperative objectives. Over almost a
century, we’ve manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith (Global Sales
Manager)
Address:
105 N 1st ST #429, SAN JOSE, CA 95103 US
Ph: 1-800-361-8290